Browsing by Keyword : Ovarian Neoplasms

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 51 of 66

Pub YearTitleAJOU Author(s)
2022A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer공태욱, 장석준
2018A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer공태욱, 백지흠, 손주혁, 유희석, 장석준
2018An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)유희석
2015Asian Society of Gynecologic Oncology International Workshop 2014.장석준
2019Asian Society of Gynecologic Oncology International Workshop 2018공태욱, 유희석, 장석준
2024Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines손주혁, 장석준
2016Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer백지흠
2011Comparative proteomic analysis of advanced serous epithelial ovarian carcinoma: possible predictors of chemoresistant disease.백지흠
2024Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006)공태욱, 김지연, 손주혁, 장석준
2011Comparison of the efficacy and toxicity between radiotherapy and chemotherapy in nodal and isolated nonnodal recurrence of ovarian cancer.백지흠
2023Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01)장석준
1996CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors.박경주
1998Diagnosis of ovarian torsion with color Doppler sonography: depiction of twisted vascular pedicle.권혁찬, 서정호, 이은주, 주희재
2011Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice.백지흠
2006Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis.장기홍
2007Dysgerminoma of the ovary with precocious puberty: a case report.유희석, 이정필, 장기홍, 한재호
2012Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease장석준
2024Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go?장석준
2011Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer.백지흠
2017Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease장석준
2003Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.장기홍
2023Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy장석준
2023Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis손주혁, 장석준
2014Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT.안영실, 윤준기, 이수진
2024Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study공태욱, 손주혁, 장석준
2023Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3공태욱
2024Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer공태욱, 손주혁
2019Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study김유찬
2024MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs권지은
2004Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer.장기홍
2023Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001)공태욱, 손주혁, 장석준
2015Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis.고영화
2019Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer공태욱, 백지흠, 손주혁, 유희석, 장석준
2017Porta hepatis debulking procedures as part of primary cytoreductive surgery for advanced ovarian cancer손주혁, 유희석, 장석준
2016Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)장석준
2018Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement장석준
2017Practice Patterns of Hereditary Ovarian Cancer Management in Korea장석준
2019Practice patterns of surgery for advanced ovarian cancer: analysis from international surveys장석준
2020Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer이진구
2012Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study김구상, 정용식
2011Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer.백지흠
2012Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer유희석, 장석준
2018Psychiatric comorbidities among ovarian cancer survivors in South Korea: A nationwide population-based, longitudinal study노오규, 오영택, 전미선, 허재성
2022Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)장석준
2006Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis.유희석, 이정필, 장기홍
2020Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study장석준
2019Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041)장석준
2018Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery공태욱, 백지흠, 손주혁, 유희석, 장석준
2023Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004)공태욱, 김지연, 손주혁, 장석준
2016Robotic single-site versus laparo-endoscopic single-site surgery for adnexal tumours: a propensity score-matching analysis공태욱, 백지흠, 유희석, 장석준
2015Role of aggressive surgical cytoreduction in advanced ovarian cancer.장석준
1 2

Browse